Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Lung Infection Article
This is a selection made from among articles on Drug Treatment Lung Infection. For a permanent link to this article, or to bookmark it for future reading, click here.
Is It Time To Start Help With Drug Treatment?
from: Drug and alcohol treatment is available to assist any individual with an addiction or substance use problem. Each treatment is based on the unique needs of that person so that they can learn to control their addiction and live normal, productive lives. Here are some suggestions to get you started on the path to recovery:
Acknowledge that the real problem is your use of drugs and/or alcohol. This first step may be the hardest step to seeking the drug addiction treatment you need. Tell those people closest to you that there is a problem with drugs and now wish to seek drug addiction treatment. Family and friends can support you through this decision. They will not judge you and will love you while seeing you through this crisis. Explain the reason you believe you began using drugs and the alternatives you would like to seek.
If utilizing your family is not an option, try a minister or clergy. You may also choose to call your local addiction help resource center. You will be able to speak to a case worker who can assist you with all of your questions and offer you several alternatives.
Second, there are teratment resources available for alcohol and drug problems. Search for the most appropriate facility in your city or state. There are several types of facilities available, both inpatient and outpatient. The social worker available at the facility will be able to advise you of the best help available for your individual needs|It is very important to get matched up to the appropriate type of treatment for your needs|A professional can point you to the most appropriate type of treatment and facility for your case}.
It is also a good idea to seek help from an individual addictions therapist in your area. Sometimes it is easier for people to speak with a therapist than anyone else| Oftentimes ir is easier to speak one on one than to go to a facility|It may be easier to start in individual therapy and be open to fifferent treatment options if suggested}. Counselors are on your side, it is not you against them. It is very important that the person you seek has specialized training in addictions. Most often doctors and psychologists do not.
Remember that the toughest part of getting help for addiction is in admitting that you have a problem to begin with. If you have begun with that part, there are many people who are willing to help you with your drug rehab treatment, but the first step is deciding to help yourself.
About Author
Tell your story! Pick up sobriety tips and tricks to enhance your life free of addictions.The author, Bill Urell MA.CAAP-II, is an addictions therapist at a leading residential treatment center. He teaches healthy life styles and life skills. Join our growing community. Visit: http://www.AddictionRecoveryBasics.com/
Source: ArticleTrader.com
Drug Treatment Lung Infection Specific links
Drug Treatment Lung Infection News
Discovery Expected to Shift Research Direction in Lupus and Asthma
Newfound details of the immune system suggest a role for never-before-considered drug classes in the treatment of allergic and autoimmune diseases, according to a University of Alabama at Birmingham study published online today in Nature Immunology. The results advance the current understanding of the way the body's initial, vague reaction to any invading organism expands into a precise and ...
Read more...Novartis Drug Afinitor® Approved By FDA As First Medication To Treat Patients With Non-Cancerous Kidney Tumors ...
Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery(2).
Read more...Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying ...
CAMBRIDGE, Mass.--(BUSINESSWIRE)-- - Global studies showed significant and sustained improvements in lung function and other measures of disease among people with a specific genetic mutation - Vertex Pharmaceuticals ...
Read more...Cut finger led to Wisconsin toddler's infection death; mother, boyfriend charged with neglect
WEST BEND, Wis. -- A 3-year-old toddler died this month of a massive streptococcus infection throughout her body after several days of neglect during which her mother refused to seek medical treatment out of fear that she would be accused of child abuse and the woman's boyfriend ignored steadily worsening symptoms, according to a criminal complaint released in Washington County Circuit Court.
Read more...Global Human Vaccines Industry
NEW YORK, May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Human Vaccines Industry http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and ...
Read more...Tiny tool can play big role against tuberculosis, UF researcher finds
( University of Florida ) Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of tuberculosis. The new technique involves vacuum filtering a sputum sample treated with household bleach and other simple chemicals. In tests of patients suspected of having TB ...
Read more...Activating genes that suppress tumors and inhibit cancer
A promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die has now been developed. The discovery may aid the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.
Read more...Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO ™ (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator ...
Read more...Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of Clinical Oncology in Chicago, IL, from June 1-5.
Read more...New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology ...
Bristol-Myers Squibb Company today announced that new data on its approved and investigational oncology compounds will be featured in ten oral presentations at the 48th Annual Meeting of the American Society of Clinical Oncology in Chicago from June 1-5.
Read more...